Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 1.6/5

Cytokinetics Inc (CYTK US)

19
Analysis
Health CareUnited States
Cytokinetics, Incorporated is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.
more
bullishBox Inc Class A
02 Mar 2024 04:32

S&P500 Index Rebalance: SPCY Additions & Large Impact

There are bunch of adds, deletes and migrations for the SnP 500/400/600 indices in March. The largest inflows are on the SP500 adds but the largest...

Logo
774 Views
Share
02 Mar 2024 21:40

Index Rebalance & ETF Flow Recap: STAR50/100, FXI, NIFTY/NEXT50, S&P500, KOSPI, Goodman, Ecopro BM

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
1k Views
Share
bullishS&P 500 INDEX
04 Oct 2022 20:20

Another Bear Market Rally Brewing?; Stick With Biotech and Construction/Engineering Names

Early indications suggest another bear market rally in $SPX, and potentially that the lows are in, helped by short-term bearish engulfing patterns...

Logo
370 Views
Share
bullishS&P 500 INDEX
09 Aug 2022 22:18

S&P 500, Nasdaq 100 Testing Key Resistance Levels; Pause Likely; Buying Biotech

$SPX is testing important resistance in the 4165-4180 area, the same resistance level we were monitoring in early June before the market tumbled 13...

Logo
391 Views
Share
bearishS&P 500 INDEX
22 Apr 2020 00:38

U.S. Equity Strategy: Several Indicators Suggest a Pullback Likely

Despite the bulls still being in control, we have several ongoing concerns and we cannot rule out the potential for a pullback. Below we highlight...

Logo
497 Views
Share
x